Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition

  • Andreas Austgulen Westin,
  • Malin Brekke,
  • Espen Molden,
  • Eirik Skogvoll,
  • Olav Spigset
  • Article
  • Metrics
  • Comments
  • Media Coverage

The affiliation for the 1st author is incomplete. Andreas Austgulen Westin is affiliated with #1 and #6.

There is an error in the caption for Fig 1, “Inclusion flow chart.” Please see the complete, correct Fig 1 caption here.

thumbnail
Download:
Fig 1. Inclusion flow chart.

Sample identification and inclusion of therapeutic drug monitoring samples of selective serotonin reuptake inhibitors and venlafaxine obtained during pregnancy. a Five analyses were excluded due to the following drug interactions: sertraline + carbamazepine (n = 1), venlafaxine + bupropion (n = 4).

https://doi.org/10.1371/journal.pone.0191508.g001

Reference

  1. 1. Westin AA, Brekke M, Molden E, Skogvoll E, Spigset O (2017) Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition. PLoS ONE 12(7): e0181082. https://doi.org/10.1371/journal.pone.0181082 pmid:28708853

Citation: Westin AA, Brekke M, Molden E, Skogvoll E, Spigset O (2018) Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition. PLoS ONE 13(1): e0191508. https://doi.org/10.1371/journal.pone.0191508

Published: January 16, 2018

Copyright: © 2018 Westin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.